- Home
- PVBC vs CRBU Comparison
PVBC vs CRBU Comparison
Compare PVBC & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVBC
- CRBU
- Stock Information
- Founded
- PVBC 1913
- CRBU 2011
- Country
- PVBC United States
- CRBU United States
- Employees
- PVBC N/A
- CRBU N/A
- Industry
- PVBC Major Banks
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- PVBC Finance
- CRBU Health Care
- Exchange
- PVBC Nasdaq
- CRBU Nasdaq
- Market Cap
- PVBC 224.8M
- CRBU 203.9M
- IPO Year
- PVBC 2015
- CRBU 2021
- Fundamental
- Price
- PVBC $12.76
- CRBU $2.14
- Analyst Decision
- PVBC Hold
- CRBU Strong Buy
- Analyst Count
- PVBC 1
- CRBU 3
- Target Price
- PVBC $12.50
- CRBU $9.33
- AVG Volume (30 Days)
- PVBC 67.1K
- CRBU 4.6M
- Earning Date
- PVBC 10-23-2025
- CRBU 11-07-2025
- Dividend Yield
- PVBC N/A
- CRBU N/A
- EPS Growth
- PVBC 131.87
- CRBU N/A
- EPS
- PVBC 0.74
- CRBU N/A
- Revenue
- PVBC $62,100,000.00
- CRBU $9,121,000.00
- Revenue This Year
- PVBC $9.73
- CRBU $8.06
- Revenue Next Year
- PVBC $4.87
- CRBU N/A
- P/E Ratio
- PVBC $17.35
- CRBU N/A
- Revenue Growth
- PVBC 12.27
- CRBU N/A
- 52 Week Low
- PVBC $10.38
- CRBU $0.66
- 52 Week High
- PVBC $13.02
- CRBU $3.54
- Technical
- Relative Strength Index (RSI)
- PVBC 59.40
- CRBU 41.51
- Support Level
- PVBC $12.48
- CRBU $2.28
- Resistance Level
- PVBC $12.82
- CRBU $3.53
- Average True Range (ATR)
- PVBC 0.17
- CRBU 0.27
- MACD
- PVBC 0.02
- CRBU -0.07
- Stochastic Oscillator
- PVBC 80.36
- CRBU 3.79
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.